While patient 2 exhibited hypergonadotropic hypogonadism similar to that of previously reported patients with pathogenic MAP3K1 variants7–11, patient 1 manifested undermasculinized external genitalia in combination with normal blood levels of gonadotropins and AMH. This evidence concerns the gene MAP3K1 and Hypergonadotropic hypogonadism.